Cargando…

Sensitivity, Specificity and Accuracy of a Novel EEG-Based Objective Test, the Cognalyzer(®), in Detecting Cannabis Psychoactive Effects

INTRODUCTION: Current standards for identifying recent cannabis use are based on body fluid testing. The Cognalyzer(®) is a novel electroencephalography (EEG) measurement device and algorithm designed to objectively characterize brainwave alterations associated with cannabis. The objective of this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDonald, Alison C., Gasperin Haaz, Israel, Qi, Weikai, Crowley, David C., Guthrie, Najla, Evans, Malkanthi, Bosnyak, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024442/ https://www.ncbi.nlm.nih.gov/pubmed/33826089 http://dx.doi.org/10.1007/s12325-021-01718-6

Ejemplares similares

Use of a Novel EEG-Based Objective Test, the Cognalyzer(®), in Quantifying the Strength and Determining the Action Time of Cannabis Psychoactive Effects and Factors that May Influence Them Within an Observational Study Framework
por: Bosnyak, Dan, et al.
Publicado: (2021)

A Randomized, Triple-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy of a Single Dose of AlphaWave(®)l-Theanine on Stress in a Healthy Adult Population
por: Evans, Malkanthi, et al.
Publicado: (2021)

A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial Investigating Two Dietary Supplements on Supporting Immune Function in Healthy Adults in a Flu Vaccine Model
por: Lewis, Erin, et al.
Publicado: (2022)

Healthy adults supplemented with a nutraceutical formulation containing Aloe vera gel, rosemary and Poria cocos enhances the effect of influenza vaccination in a randomized, triple-blind, placebo-controlled trial
por: Lewis, Erin D., et al.
Publicado: (2023)

Changing the Tone of Clinical Study Design in the Cannabis Industry
por: Antony, Joseph M, et al.
Publicado: (2020)

Erratum to “Changing the tone of clinical study design in the cannabis industry”
por: Antony, Joseph M., et al.
Publicado: (2020)

Pain Bloc-R Alleviates Unresolved, Non-Pathological Aches and Discomfort in Healthy Adults—A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
por: Evans, Malkanthi, et al.
Publicado: (2020)

Efficacy of a natural mineral complex in North American adults with osteoarthritis of the knee: a randomized double-blind placebo-controlled study
por: Evans, Malkanthi, et al.
Publicado: (2014)

Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals
por: Evans, Malkanthi, et al.
Publicado: (2022)

Effectiveness of Hydrogen Rich Water on Antioxidant Status of Subjects with Potential Metabolic Syndrome—An Open Label Pilot Study
por: Nakao, Atsunori, et al.
Publicado: (2010)

A randomized, double-blind, placebo-controlled clinical trial evaluating Dermytol(®) cream for the treatment of actinic keratoses
por: Evans, Malkanthi, et al.
Publicado: (2014)

The Essentials of a Global Index for Cognitive Function
por: Antony, Joseph Mathew, et al.
Publicado: (2017)

A randomized, triple‐blind, placebo‐controlled, parallel study to evaluate the efficacy of a freshwater marine collagen on skin wrinkles and elasticity
por: Evans, Malkanthi, et al.
Publicado: (2020)

Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial
por: Crowley, David C., et al.
Publicado: (2009)

Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol(®) on glycemic control of subjects with impaired fasting glucose
por: Evans, Malkanthi, et al.
Publicado: (2015)

A Whole-Food-Based Health Product (A-F Betafood(®)) Improves Gallbladder Function in Humans at Risk of Gallbladder Insufficiency: A Randomized, Placebo-Controlled Clinical Trial
por: Evans, Malkanthi, et al.
Publicado: (2020)

Efficacy of a novel formulation of L-Carnitine, creatine, and leucine on lean body mass and functional muscle strength in healthy older adults: a randomized, double-blind placebo-controlled study
por: Evans, Malkanthi, et al.
Publicado: (2017)

Cannabis Legalization in Canada: Reflections on Public Health and the Governance of Legal Psychoactive Substances
por: Crépault, Jean-François
Publicado: (2018)

Wastewater analysis for new psychoactive substances and cocaine and cannabis in a Northern Ireland Prison
por: Davies, Bethan, et al.
Publicado: (2023)

Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study
por: Zongo, Arsène, et al.
Publicado: (2021)

Psychoactive Medication and Traffic Safety
por: Verster, Joris C., et al.
Publicado: (2009)

A Framework for the Objective Assessment of Registration Accuracy
por: Pizzorni Ferrarese, Francesca, et al.
Publicado: (2014)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

Identification of Psychoactive Metabolites from Cannabis sativa, Its Smoke, and Other Phytocannabinoids Using Machine Learning and Multivariate Methods
por: Jagannathan, Ramesh
Publicado: (2020)

In silico discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery
por: Khattab, Amira R, et al.
Publicado: (2022)

Examining the Efficacy of a Very-Low-Carbohydrate Ketogenic Diet on Cardiovascular Health in Adults with Mildly Elevated Low-Density Lipoprotein Cholesterol in an Open-Label Pilot Study
por: Tzenios, Nikolaos, et al.
Publicado: (2022)

Bioavailability of calcium in an enriched postbiotic system compared to calcium citrate in healthy postmenopausal females; A randomized, double-blind, comparator-controlled, crossover study
por: Friling, Marina, et al.
Publicado: (2023)

Psychoactive drugs and driving
por: Parekh, Vanita
Publicado: (2019)

Use of (13)C-qNMR Spectroscopy for the Analysis of Non-Psychoactive Cannabinoids in Fibre-Type Cannabis sativa L. (Hemp)
por: Marchetti, Lucia, et al.
Publicado: (2019)

Antiseizure Effects of Fully Characterized Non-Psychoactive Cannabis sativa L. Extracts in the Repeated 6-Hz Corneal Stimulation Test
por: Costa, Anna-Maria, et al.
Publicado: (2021)

Identification and Quantification of the Main Psychoactive Ingredients of Cannabis in Urine Using Excitation–Eemission Matrix Fluorescence Coupled with Parallel Factor Analysis
por: Cui, Sheng-Feng, et al.
Publicado: (2023)

Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse
por: Correia, Beatriz, et al.
Publicado: (2022)

Medical use and misuse of psychoactive prescription medications among US youth and young adults
por: Agaku, Israel, et al.
Publicado: (2021)

Psychoactive Drugs and Quality of Life
por: Ventegodt, Soren, et al.
Publicado: (2003)

Editorial: Novel Psychoactive Drugs
por: Fattore, Liana, et al.
Publicado: (2019)

Psychoactive Drugs in Plastic Surgery
por: Davison, Steven P., et al.
Publicado: (2017)

Toxicology and Analysis of Psychoactive Tryptamines
por: Malaca, Sara, et al.
Publicado: (2020)

Psychoactive Prescribing in Assisted Living
por: Zimmerman, Sheryl, et al.
Publicado: (2020)

A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History
por: Berl, Volker, et al.
Publicado: (2022)

ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
por: Engelgardt, Piotr, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ma2q72r52oe48948u85kbbsmsh